Abstract
Objectives Though widely reported by patients, cognitive symptoms associated with bipolar disorder (BD), including deficits in executive function, memory, attention, and timing are under-studied. Work suggests that individuals with BD show impairments in sub-second interval timing tasks (ITT), however, results have been inconclusive regarding supra-second time perception in BD patients. Additionally, the effects of mood or medication status on time perception in BD patients are debated in the literature.
Methods To address this, the present work administered a supra-second ITT concurrent with electroencephalographic (EEG) recordings to patients with BD and neuronormative controls. As this task is known to elicit frontal theta oscillations, which can be abnormal in psychiatric populations, signal from the Fz lead was analyzed at rest and during the task.
Results & Conclusions As hypothesized, results suggest that individuals with BD show impairments in supra-second ITT performance compared to neuronormative controls. Frontal theta power was also reduced compared to controls during the ITT but not during rest. Finally, timing impairments remain detectible in BD patients independent of mood state and use of antipsychotic medication. This suggests that supra-second interval timing deficits are a key characteristic observed in BD. Together with previous work, these findings point to critical timing impairments in BD patients across a wide range of timing modalities and durations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by: Bipolar Disorders Research Program of Excellence via the University of Iowa Roy J. Carver Charitable Trust and the University of Iowa Neuroscience Institute
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of the University of Iowa gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: Bipolar Disorders Research Program of Excellence via the University of Iowa Roy J. Carver Charitable Trust and the University of Iowa Neuroscience Institute
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author.
